myocytes (MCT 0.08 5 0.01 mm vs CON 0.04 5 0.01 mm, P < 0.001). MCT n = 25 cells; CON n = 18 cells, 2 way RM ANOVA. We conclude that the shorter resting SL in MCT myocytes is due to the formation of Ca 2þ -independent cross-bridges, we speculate that these are formed in response to disturbances in cellular metabolism, by mechanisms currently under investigation. Supported by the BHF and MRC
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A Single Strain-Based Growth Law Predicts Concentric and Eccentric Cardiac Growth during Pressure and Volume Overload Roy Kerckhoffs, Jeffrey Omens, Andrew McCulloch. University of California, San Diego, La Jolla, CA, USA. Adult cardiac muscle adapts to changes in the environment by growth and remodeling via a variety of mechanisms. Hypertrophy develops when the heart is subjected to chronic mechanical overload. In ventricular pressure overload (due to aortic stenosis) the heart typically reacts by concentric hypertrophic growth, characterized by wall thickening due to myocyte thickening when sarcomeres are added in parallel. In ventricular volume overload, an increase in filling pressure (due to mitral regurgitation) leads to eccentric hypertrophy as myocytes grow axially by adding sarcomeres in series leading to ventricular cavity enlargement that is typically accompanied by some wall thickening. The specific biomechanical stimuli that stimulate different modes of hypertrophy are still poorly understood. Recently, we proposed that cardiac myocytes grow longitudinally to maintain a preferred sarcomere length in response to increased fiber strain and axially to maintain interfilament lattice spacing in response to increased crossfiber strain. Here, we test whether this growth law is able to predict concentric and eccentric hypertrophy in response to aortic stenosis and mitral valve regurgitation, respectively, in a computational model of the adult canine heart coupled to a closed loop model of circulatory hemodynamics. A finite element model of the beating canine ventricles coupled to the circulation that was used. After inducing valve alterations, the ventricles were allowed to adapt in shape in response to mechanical stimuli over time. The proposed growth law was able to reproduce major acute and chronic physiological responses when integrated with comprehensive models of the pressure-and volume-overloaded canine heart, coupled to a closed-loop circulation. We conclude that strainbased biomechanical stimuli consistent with in-vitro studies of myocyte stretch responses can drive cardiac growth, including wall thickening during pressure overload. Background: Hypertrophic cardiomyopathy (HCM) is frequently caused by mutations in genes encoding sarcomeric proteins. Previously, we observed a reduced maximal force generating capacity (Fmax) of cardiomyocytes from HCM patients with mutations in myosin-binding protein-C (MYBPC3). In this study we investigated the contribution of myofibril density (MyoD) and cross-sectional area (CSA) to the reduction in Fmax. Methods: We measured Fmax and CSA of single permeabilized ventricular cardiomyocytes of 27 HCM patients with mutations in MYBPC3, myosin heavy chain: MYH7, troponin T: TNNT2 and troponin I: TNNI3 and 10 non-failing donor hearts. MyoD was calculated as the sum of myofibril area related to cell area assessed by electron microscopy. Results: Average Fmax was significantly lower in HCM groups compared to donor ( Figure A) . Figure B shows that MyoD of HCM hearts was reduced compared to donors. CSA of HCM hearts (529548mm2) was significantly higher compared to donors (342512mm2). Linear regression analysis revealed a significant negative linear relationship between CSA and Fmax (R2= 0.50, b=-0.023, p=0.014). (SPOC) is a physiological state induced in striated muscle fibres under conditions of partial activation. SPOC is characterised by repetitive auto-oscillations between cycles of rapid lengthening and slow shortening that correlate with diastole and systole respectively. We activate cardiomyocytes using ADP-induced SPOC and Ca2þ induced SPOC. Ca-SPOC correlates well with heart rate observed in a number of animal models. The current study quantifies contractile performance of cardiomyocytes isolated from human dilated and hypertrophic cardiomyopathies (some with known mutations) and compares them with age-matched non-failing donors. Measured parameters of contractile performance include the velocity, period and amplitude of contraction, relaxation and SPOC-wave. We compare changes in contractile performance between (1) failing and non-failing hearts, (2) hearts from a wide range of donor ages, and (3) differences between ADPand Ca-SPOC. These observations are then related to patient clinical data (e.g. ejection fraction). Interestingly, human heart samples flash frozen (À200 C) within minutes of the loss of coronary blood flow can be re-activated even after up to 20 years of storage. Cardiac muscle fibres from the left atria and left ventricles, interventricular septa and papillary muscles were specially defrosted prior to microdissection. Length changes were measured using a Leica SP5 multi-photon microscope and then averaged at high spatial and temporal resolution. Preliminary data identify measureable changes in contractile performance between non-failing and failing hearts. Samples of hypertrophic cardiomyopathy exhibit decreased rates of relaxation consistent with their clinical diagnosis. These observations reveal SPOC to yield a range of functional parameters that can be used to evaluate the functional state of human heart muscle fibres. Thus, SPOC may prove to be a valuable measurement that can objectively assess the state of human heart failure. It is generally believed that the rhythm of heartbeat is controlled by electric stimulations produced by pacemaker cells. However, sarcomeres in cardiac myofibrils exhibit spontaneous rhythmic oscillations of sarcomere length (SL) and force under partial activation conditions (i.e., SPOC). SPOC occurs either at pCa~6.0 (Ca-SPOC ) or at the coexistence of MgADP and Pi in the absence of Ca 2þ (ADP-SPOC) (Ishiwata et al., 2011) . We have reported that the SPOC period correlates strongly with the resting heart rate in various animal species (Sasaki et al., 2006) . In the present study, to test whether SPOC plays a key role in the regulation of heartbeat, we performed analyses on the waveform properties of SPOC by using rat neonatal cardiomyocytes expressing AcGFP in the Z-lines. First, we found that SPOC occurs in the neonatal myocytes treated with ionomycin at pCa~6.0 (pCa adjusted by Ca/EGTA), viz., in the presence Monday, February 27, 2012 353a 
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